As of 2025-07-18, the Fair Value of Oxford BioMedica PLC (OXB.L) is -215.40 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 362.50 GBP, the upside of Oxford BioMedica PLC is -159.42%.
With the market price of 362.50 GBP and our fair value calculation, Oxford BioMedica PLC (OXB.L) is not a good investment. Investing in OXB.L stocks now will result in a potential loss of 159.42%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -6.25 | 19.01 | -39.16 | -157.49 | -43.19 | -45.41 |
| YoY growth | 61.13% | 404.42% | -305.97% | -302.20% | 72.58% | -14.01% |
| Market Cap (mil) | 363.43 |
| P/E | |
| Forward P/E |
| EPS | -43.08 |
| Avg earnings growth rate | -14.01% |
| TTM earnings | -43.19 |